Anti-CEA antibody (Albert Einstein)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAnti-CEA antibody (Albert Einstein)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyCell and gene therapy > Gene therapy
Mechanisms of ActionCarcinoembryonic antigen related cell adhesion molecule 5 antagonists
TargetsCarcinoembryonic antigen related cell adhesion molecule 5
Therapy Area/IndicationsAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlbert Einstein College Of Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlbert Einstein College Of Medicine Inc
Active IndicationsN/A
Inactive IndicationsAdenocarcinoma

Other Information

ATC CodeN/A
Related LinksN/A